VINBLASTINE
Urethral Cancer
University of Southern CaliforniaSmall moleculePhase 3Dormant
BBB
73/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 62/ 100
- Competitive Position
- 95/ 100
Competitive context
9 Active assets in the Urethral Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin National Cancer Institute (NCI) | Phase 3 | BBB |
CIS-DIAMMINEDICHLOROPLATINUM II University of Southern California | Phase 3 | BBB |
METHOTREXATE University of Southern California | Phase 3 | BBB |
Inno-206 University of Southern California | Phase 3 | BB |
VINBLASTINE University of Southern California | Phase 3 | BB |
View all 39 →
Same molecule, other indications
VINBLASTINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →